crispr
CRISPR patent revoked at the EPO
By Niklas Mattsson | Posted on January 31, 2018
The CRISPR system has revolutionised the gene technology field, opening up for a multitude of genetic engineering possibilities and harbouring huge potential for the treatment of diseases. In particular, one version of the system known as CRISPR/Cas9, has been modified to edit genomes. It is commonly called a “gene scissor”, i.e. it can cut a...
Filed under: Insights
Broad Institute maintains patents to Gene Scissors in the US
By Joanna Applequist | Posted on February 17, 2017
The CRISPR-Cas9 technology, the so called “gene scissors” which allow for targeted genome-editing, is subject to a patent dispute between two research teams lead by Jennifer Doudna at UC Berkeley and Emanuelle Charpentier then at the University of Vienna on one hand, and Feng Zhang’s lab at the Broad Institute and MIT on the other....
Tags: cas9, crispr, crispr-cas9
Recent contributors
Counsel, AU and NZ Patent Attorney
Senior Associate, China Patent Attorney
Associate, Attorney at Law
Counsel, European Patent Attorney
Partner, Attorney at Law, Business Area Manager
Partner, European Patent Attorney